Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 52 min ago
Peer-reviewedCC BYLung

Outcomes with Catheter-Directed Thrombolysis versus Mechanical Thrombectomy for Patients with Intermediate/High Risk Pulmonary Embolism: A Meta-Analysis of 24,090 Patients.

10 affiliations
  1. 1Faculty of Medicine, Beni-Suef University, Ihnasya, Abdellatif Qasem Street, Beni Suef, Egypt. [email protected].
  2. 2Faculty of Medicine, Nahda University in Beni Suef (NUB), Beni Suef, Egypt.
  3. 3Florida Atlantic University, Boca Raton, FL, USA.
  4. 4Faculty of Medicine, Tanta University, Tanta, Egypt.
  5. 5Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan.
  6. 6Faculty of Medicine, Beni-Suef University, Ihnasya, Abdellatif Qasem Street, Beni Suef, Egypt.
  7. 7Department of Clinical and Experimental Medicine, University of Messina, Messina, Italy.
  8. 8Division of Cardiovascular Medicine, Knight Cardiovascular Institute, Oregon Health and Science University, Portland, OR, USA.
  9. 9Institute of Medicine, University of Tsukuba, Tsukuba, Japan.
  10. 10Division of Cardiovascular Medicine, Gill Heart and Vascular Institute, University of Kentucky, Lexington, KY, USA.

Abstract

Background

Randomized trials comparing the outcomes with catheter-directed medical thrombolysis (CDT) versus mechanical thrombectomy (MT) for patients with intermediate/high risk pulmonary embolism (PE) are limited. This meta-analysis aimed to assess the clinical outcomes after CDT versus MT for patients with intermediate/high risk PE.Methods

Eligible studies compared CDT and MT for patients with intermediate/high risk PE underwent catheter-based therapies were retrieved from a comprehensive literature search for PubMed, Web of Science, Scopus, and Cochrane CENTRAL through June 2026. Outcomes included all-cause mortality, major bleeding, and the length of intensive care unit (ICU) stay. Summary estimates were analyzed using a random effects model.Results

A total of 18 studies (24,090 intermediate/high risk patients) were eligible for the analysis. CDT was associated with longer length of intensive care unit (ICU) stay (mean difference: 1.01 days, 95% confidence interval [CI] 0.87-1.15) compared with MT. While there was no statistical difference between the two groups regarding the risk of all-cause mortality (risk ratio [RR] 0.88, 95% CI 0.76-1.01, p = 0.068) and major bleeding (RR 1.07, 95% CI 0.74-1.55, p = 0.705). Similarly, the incidence of other clinical outcomes; all-cause readmission, PE-related readmission, blood transfusion rates, length of hospital stay, cardiac arrest, and stroke, were similar between the two groups.Conclusion

Among patients with intermediate/high risk PE treated with catheter-based therapies, there was no difference regarding the clinical outcomes between CDT and MT, but CDT was associated with a longer ICU stay. Larger, well designed randomized trials are needed to confirm these findings.

Related

  1. Cost-Effectiveness of Large-Bore Mechanical Thrombectomy Versus Catheter-Directed Thrombolysis for Intermediate-Risk Pulmonary Embolism: A PEERLESS Randomized Controlled Trial Post Hoc Analysis
    Samuel Horr, Orestis Pappas, Ripal T. Gandhi +11
    Journal of the Society for Cardiovascular Angiography & InterventionsPeer-reviewedCC BY 4.0Full textGeneral medicinePMCEurope PMC
  2. Catastrophic High-Risk Pulmonary Embolism With Recurrent Cardiac Arrest Successfully Treated With Rescue Mechanical Thrombectomy After Systemic Thrombolysis
    Vincenzo Cuzzone, Alessia Di Bartolomeo, Nicola Porchetta +2
    CureusPeer-reviewedCC BYFull textCardiovascular medicineSurgery & anaesthesiaEurope PMCPMC
  3. Large-bore Mechanical Thrombectomy for Treatment of Intermediate-high Risk Pulmonary Embolism: A Single-center Australian Experience.
    Roy Kingsley Wong, Goran Mitreski, Hui Yin Lim +7
    Interventional radiology (Higashimatsuyama-shi (Japan)Peer-reviewedCC BY-NCFull textGeneral medicineEurope PMCPMC
  4. Effects of mechanical thrombectomy combined with anticoagulation vs anticoagulation monotherapy for acute intermediate-high risk pulmonary embolism: study protocol for a randomized controlled trial (CAPE study, ChiCTR2500095253, https://www.medicalresearch.org.cn/clinicalResearch/researchInfo?id=c57630b7-51ec-4b24-83e1-85b9c0a835d6).
    Qiang Huang, Lin Feng, Lin Liu +13
    TrialsPeer-reviewedCC BY-NC-NDFull textClinical trials & evidence synthesisEurope PMCPMC
  5. Quality of life and clinical outcomes after large-bore mechanical thrombectomy for submassive pulmonary embolism
    Jessica Katsiroubas, MD, Susan Basharkhah, MD, Kevin Leong, MD +4
    Journal of Vascular Surgery: Venous and Lymphatic DisordersPeer-reviewedCC BYFull textCardiovascular medicineSurgery & anaesthesiaDOAJ
BibTeX
@article{sayed2026outcomes,
  title = {{Outcomes with Catheter-Directed Thrombolysis versus Mechanical Thrombectomy for Patients with Intermediate/High Risk Pulmonary Embolism: A Meta-Analysis of 24,090 Patients.}},
  author = {Mohamed Saad Sayed and Doaa Mohamed Gebaly and Hasan Ilyas and Rawan Abdelhamed and Waleed Mohaned Rasheed and Hossam Hamdy and Lydia Melad and Giuseppe Andò and Toshiki Kuno and Islam Y Elgendy},
  journal = {Lung},
  year = {2026},
  month = nov,
  doi = {10.1007/s00408-026-00950-7},
  url = {https://europepmc.org/article/MED/43007443},
  note = {CC BY},
}
RIS
TY  - JOUR
TI  - Outcomes with Catheter-Directed Thrombolysis versus Mechanical Thrombectomy for Patients with Intermediate/High Risk Pulmonary Embolism: A Meta-Analysis of 24,090 Patients.
AU  - Mohamed Saad Sayed
AU  - Doaa Mohamed Gebaly
AU  - Hasan Ilyas
AU  - Rawan Abdelhamed
AU  - Waleed Mohaned Rasheed
AU  - Hossam Hamdy
AU  - Lydia Melad
AU  - Giuseppe Andò
AU  - Toshiki Kuno
AU  - Islam Y Elgendy
PY  - 2026
DA  - 2026/11/10
JO  - Lung
DO  - 10.1007/s00408-026-00950-7
UR  - https://europepmc.org/article/MED/43007443
AB  - Background  Randomized trials comparing the outcomes with catheter-directed medical thrombolysis (CDT) versus mechanical thrombectomy (MT) for patients with intermediate/high risk pulmonary embolism (PE) are limited. This meta-analysis aimed to assess the clinical outcomes after CDT versus MT for patients with intermediate/high risk PE.Methods  Eligible studies compared CDT and MT for patients with intermediate/high risk PE underwent catheter-based therapies were retrieved from a comprehensive literature search for PubMed, Web of Science, Scopus, and Cochrane CENTRAL through June 2026. Outcomes included all-cause mortality, major bleeding, and the length of intensive care unit (ICU) stay. Summary estimates were analyzed using a random effects model.Results  A total of 18 studies (24,090 intermediate/high risk patients) were eligible for the analysis. CDT was associated with longer length of intensive care unit (ICU) stay (mean difference: 1.01 days, 95% confidence interval [CI] 0.87-1.15) compared with MT. While there was no statistical difference between the two groups regarding the risk of all-cause mortality (risk ratio [RR] 0.88, 95% CI 0.76-1.01, p = 0.068) and major bleeding (RR 1.07, 95% CI 0.74-1.55, p = 0.705). Similarly, the incidence of other clinical outcomes; all-cause readmission, PE-related readmission, blood transfusion rates, length of hospital stay, cardiac arrest, and stroke, were similar between the two groups.Conclusion  Among patients with intermediate/high risk PE treated with catheter-based therapies, there was no difference regarding the clinical outcomes between CDT and MT, but CDT was associated with a longer ICU stay. Larger, well designed randomized trials are needed to confirm these findings.
SN  - 0341-2040
SN  - 1432-1750
ER  -